KhanI,WaqasM,ShamimMS,,2017,Prognostic significance of IDH 1 mutation in patients with glioblastoma multiforme,J Pak Med Assoc,67,816,7
NordenAD,YoungGS,SetayeshK,MuzikanskyA,KlufasR,RossGL,,2008,Bevacizumab for recurrent malignant gliomas; efficacy, toxicity, and patterns of recurrence,Neurology,70,779,87
Indian J Endocr Metab De BonisP,AnileC,PompucciA,FiorentinoA,BalducciM,ChiesaS,,2013,The influence of surgery on recurrence pattern of glioblastoma,Clin Neurol Neurosurg,115,37,43
OppenlanderME,WolfAB,SnyderLA,BinaR,WilsonJR,CoonsSW,,2014,An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity: clinical article,J Neurosurg,120,846,53
De Bonis P, Fiorentino A, Anile C, Balducci M, Pompucci A, Chiesa S, et al. The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma.
Clin Neurol Neurosurg. 2013; 115: 883-6.
BrandesAA,BartolottiM,TosoniA,PoggiR,BartoliniS,PaccapeloA,,2016,Patient outcomes following second surgery for recurrent glioblastoma,Future Oncol,12,1039,44
SughrueME,SheeanT,BonneyPA,MaurerAJ,TeoC,,2015,Aggressive repeat surgery for focally recurrent primary glioblastoma: outcomes and theoretical framework,Neurosurg focus,38,E11,
Skeie BS, Enger PO, Brogger J, Ganz JC, Thorsen F, Heggdal JI, et al. Gamma knife surgery versus reoperation for recurrent glioblastoma multiforme. World Neurosurgery.
2012; 78: 658-69.
Suchorska B, Weller M, Tabatabai G, Senft C, Hau P, Sabel MC, et al. Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent
glioblastoma - results from the DIRECTOR trial. Neuro-oncol. 2016; 18: 549-56.